BDX BECTON DICKINSON & CO

NYSE bd.com


$ 195.98 $ 6.03 (3.18 %)    

Friday, 21-Nov-2025 12:09:51 EST
QQQ $ 591.66 $ 4.33 (0.74 %)
DIA $ 464.59 $ 5.14 (1.12 %)
SPY $ 660.95 $ 5.94 (0.91 %)
TLT $ 89.30 $ -0.36 (-0.4 %)
GLD $ 376.11 $ 2.12 (0.57 %)
$ 189.58
$ 190.39
$ 195.74 x 109
$ 195.93 x 100
$ 190.39 - $ 196.11
$ 161.47 - $ 247.99
2,588,795
na
54.34B
$ 0.49
$ 34.28
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-Q
4 11-27-2024 09-30-2024 10-K
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-01-2024 12-31-2023 10-Q
8 11-21-2023 09-30-2023 10-K
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-02-2023 12-31-2022 10-Q
12 11-22-2022 09-30-2022 10-K
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-03-2022 12-31-2021 10-Q
16 11-24-2021 09-30-2021 10-K
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-04-2021 12-31-2020 10-Q
20 11-25-2020 09-30-2020 10-K
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-06-2020 12-31-2019 10-Q
24 11-27-2019 09-30-2019 10-K
25 08-06-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-05-2019 12-31-2018 10-Q
28 11-21-2018 09-30-2018 10-K
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 02-06-2018 12-31-2017 10-Q
32 11-22-2017 09-30-2017 10-K
33 08-03-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-02-2017 12-31-2016 10-Q
36 11-23-2016 09-30-2016 10-K
37 08-04-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-05-2016 12-31-2015 10-Q
40 11-25-2015 09-30-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-maintains-sector-perform-on-becton-dickinson-lowers-price-target-to-202

RBC Capital analyst Shagun Singh maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and lowers the price target fro...

 piper-sandler-maintains-neutral-on-becton-dickinson-lowers-price-target-to-190

Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and lowers the price target from $20...

 becton-dickinson-sees-high-single-digit-profit-growth-ahead-plans-share-buybacks-from-waters-deal

Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments des...

 becton-dickinson-sees-fy2026-adj-eps-1475-1505-vs-1438-est

Becton Dickinson (NYSE:BDX) is looking for FY2026 Adj EPS of $14.75-$15.05 vs $14.38 analyst estimate..

 becton-dickinson-q4-adj-eps-396-beats-392-estimate-sales-5890b-miss-5902b-estimate

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.92 ...

 becton-dickinson-and-company-announces-full-enrollment-in-its-pivotal-agility-investigational-device-exemption-trial-in-patients-with-peripheral-arterial-disease

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the i...

 bd-receives-fda-510k-clearance-and-conformit-europenne-marking-in-eu-for-enteric-bacterial-panel-and-enteric-bacterial-panel-plus-for-bd-cor-system

BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S.

 bd-unveils-bd-incada-connected-care-platform-ai-enabled-cloud-based-platform-that-unifies-bd-device-data-into-one-intelligent-ecosystem

BD (Becton, Dickinson and Company) (NYSE:BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care ...

 bd-cfo-set-to-exit-company-this-december-stock-falls

Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque int...

 rbc-capital-reiterates-sector-perform-on-becton-dickinson-maintains-211-price-target

RBC Capital analyst Shagun Singh reiterates Becton Dickinson (NYSE:BDX) with a Sector Perform and maintains $211 price target.

 becton-dickinson-sees-q4-sales-5900b-vs-5912b-est

Becton Dickinson (NYSE:BDX) sees Q4 sales of $5.900 billion vs $5.912 billion analyst estimate.

 becton-dickinson-narrows-fy2025-sales-guidance-from-21800b-21900b-to-21800b-vs-21863b-est

Becton Dickinson (NYSE:BDX) narrows FY2025 sales outlook from $21.800 billion-$21.900 billion to $21.800 billion vs $21.863 bil...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION